<DOC>
	<DOCNO>NCT02172573</DOCNO>
	<brief_summary>The objective study evaluate efficacy safety SND 919 ( pramipexole ) tablet administer combination L-dopa patient Parkinson 's disease use placebo bromocriptine tablet comparators double-blind design ( phase III comparative study ) .</brief_summary>
	<brief_title>Safety Efficacy Pramipexole Bromocriptine Combined With L-dopa Parkinson 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Pramipexole</mesh_term>
	<mesh_term>Bromocriptine</mesh_term>
	<criteria>Patients diagnosis Parkinson 's disease ( include juvenile parkinsonism ) Patients meet follow inclusion criterion Patients least 20 year age In outpatient either sex Patients stage modify Hoehn Yahr scale Patients treat Ldopa follow clinical condition problem Patients wearingoff phenomenon Patients onoff phenomenon Patients sufficient amount Ldopa administer owe occurrence adverse event Patients effect Ldopa attenuate Patients dose increase Ldopa refrain Patients freeze phenomenon Patients treat dopamine agonist ( bromocriptine , pergolide mesylate , talipexole hydrochloride ) . Patients treat dopamine agonist least 4 week start study ( day give informed consent ) eligible study Patients history hypersensitivity ergot preparation Patients psychiatric symptom confusion , hallucination , delusion , excitement , delirium , abnormal behaviour Patients subjective symptom derive orthostatic hypotension Patients hypotension ( systolic blood pressure le 100 mmHg ) Patients wiht Raynaud disease Patients peptic ulcer Patients complication severe cardiac , renal , hepatic disease etc . Patients current past history epilepsy Women may pregnant lactate woman Patients receive investigational product receive investigational product within 6 month study Patients incompetent give consent Others judge investigator coinvestigator ineligible subject</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>